Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Healthy
Interventions: Drug: PF-03382792 0.5mg; Drug: PF-03382792 1.5 mg; Drug: PF-03382792 5 mg; Drug: PF-03382792 15 mg
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Alzheimer Disease
Intervention: Other: No intervention
Sponsor: Pfizer
Completed - verified March 2010
Condition: Diabetic Peripheral Neuropathy
Interventions: Biological: Tanezumab; Biological: placebo
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Conditions: Osteoarthritis; Arthritis; Pain
Interventions: Biological: Placebo; Biological: tanezumab; Biological: tanezumab; Biological: tanezumab; Biological: tanezumab
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Healthy Volunteer
Intervention: Drug: PF-02341066
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Huntington Disease
Intervention: Drug: Dimebon (latrepirdine)
Sponsors: Medivation, Inc.; Pfizer
Active, not recruiting - verified March 2010
Condition: Epilepsy
Intervention:
Sponsors: The Epilepsy Study Consortium; Eisai Inc.; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; H. Lundbeck A/S; Pfizer; Supernus Pharmaceuticals, Inc.; UCB, Inc.
Enrolling by invitation - verified March 2010
Conditions: Smoking Cessation; Depression
Interventions: Drug: varenicline; Drug: placebo
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Condition: Healthy
Interventions: Drug: 330 mg pregabalin controlled release; Drug: 330 mg pregabalin controlled release; Drug: 330 mg pregabalin controlled release; Drug: Drug: 300 mg pregabalin immediate release
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: Placebo
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Medication Non-Adherence
Interventions: Behavioral: No Patient Counseling; Behavioral: Adherence Counseling
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Conditions: Growth Disorders; Intrauterine Growth Retardation
Interventions: Drug: Genotonorm; Drug: Genotonorm; Drug: Genotonorm
Sponsor: Pfizer
Completed - verified February 2010
Conditions: Metastatic Renal Cell Carcinoma; Gastrointestinal Stromal Tumors
Intervention: Drug: Sunitinib malate
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Conditions: Candidemia; Invasive Aspergillosis; Serious Fungal Infections; Oesophageal Candidiasis
Intervention: Drug: voriconazole tablet
Sponsor: Pfizer
Completed - verified February 2010
Conditions: Candidemia; Invasive Aspergillosis; Serious Fungal Infections
Intervention: Drug: voriconazole IV
Sponsor: Pfizer
Completed - verified February 2010
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: University of Oulu; Pfizer
Recruiting - verified February 2010
Condition: Triple Negative Breast Cancer
Interventions: Drug: Cisplatin; Drug: PF-01367338; Drug: Cisplatin
Sponsors: Hoosier Oncology Group; Pfizer
Recruiting - verified February 2010
Condition: Uremic Pruritus
Interventions: Drug: Pregabalin; Drug: Placebo
Sponsor: Shaare Zedek Medical Center
Not yet recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Placebo; Drug: Tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Condition: Alcohol Dependence
Interventions: Drug: Varenicline; Drug: Placebo
Sponsors: Johannes Gutenberg University Mainz; Pfizer
Not yet recruiting - verified December 2009
Condition: Breast Cancer
Intervention: Drug: Paclitaxel,Gemcitabine,Sunitinib
Sponsors: National Cancer Center, Korea; Pfizer; CJ Cheiljedang Corporation
Recruiting - verified January 2009
All Categories ... Pharma Companies » ... Pfizer 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
